Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Robert W Duggan. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Robert W Duggan har rapporterat innehav eller affärer i följande företag:
| Värdepapper | Titel | Senaste rapporterade innehav |
|---|---|---|
| US:SMMT / Summit Therapeutics Inc. | Co-Chief Executive Officer, Director, 10% Owner | 25 824 474 |
| US:PLSE / Pulse Biosciences, Inc. | Director, 10% Owner | 48 370 047 |
| US:AKAO / Achaogen, Inc. | 10% Owner | 5 555 414 |
| US:PCYC / Pharmacyclics | Chairman and CEO, Director, 10% Owner | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Robert W Duggan. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp PLSE / Pulse Biosciences, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i PLSE / Pulse Biosciences, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i PLSE / Pulse Biosciences, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
| Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
|---|---|---|---|---|---|---|---|
| Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Robert W Duggan som avslöjats för Securities Exchange Commission (SEC).
| Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-04 |
|
4 | SMMT |
Summit Therapeutics Inc.
Common Stock |
P - Purchase | 100 000 | 25 824 474 | 0,39 | 14,60 | 1 460 000 | 377 037 320 | |
| 2026-05-15 |
|
4/A | PLSE |
PULSE BIOSCIENCES, INC.
Common Stock |
P - Purchase | 660 233 | 48 370 047 | 1,38 | 19,69 | 12 999 988 | 952 406 225 | |
| 2026-05-11 |
|
4 | PLSE |
PULSE BIOSCIENCES, INC.
Common Stock |
P - Purchase | 660 233 | 48 211 433 | 1,39 | 19,69 | 12 999 988 | 949 283 116 | |
| 2025-10-23 |
|
4 | SMMT |
Summit Therapeutics Inc.
Common Stock |
P - Purchase | 26 680 | 76 680 | 53,36 | 18,74 | 499 983 | 1 436 983 | |
| 2025-10-23 |
|
4 | SMMT |
Summit Therapeutics Inc.
Common Stock |
A - Award | 266 808 | 25 724 474 | 1,05 | 18,74 | 4 999 982 | 482 076 643 | |
| 2025-10-23 |
|
4 | SMMT |
Summit Therapeutics Inc.
Common Stock |
A - Award | 13 980 789 | 570 073 879 | 2,51 | 18,74 | 261 999 986 | 10 683 184 492 | |
| 2025-09-12 |
|
4 | PLSE |
PULSE BIOSCIENCES, INC.
Common Stock |
P - Purchase | 34 659 | 47 551 200 | 0,07 | 14,66 | 508 101 | 697 100 592 | |
| 2025-09-12 |
|
4 | PLSE |
PULSE BIOSCIENCES, INC.
Common Stock |
P - Purchase | 145 140 | 47 709 140 | 0,31 | 14,41 | 2 091 467 | 687 488 707 | |
| 2025-09-12 |
|
4 | PLSE |
PULSE BIOSCIENCES, INC.
Common Stock |
P - Purchase | 12 800 | 47 564 000 | 0,03 | 14,77 | 189 056 | 702 520 280 | |
| 2025-09-11 |
|
4 | SMMT |
Summit Therapeutics Inc.
Common Stock |
P - Purchase | 5 000 | 556 093 090 | 0,00 | 18,07 | 90 350 | 10 048 602 136 | |
| 2025-09-11 |
|
4 | SMMT |
Summit Therapeutics Inc.
Common Stock |
P - Purchase | 333 394 | 556 088 090 | 0,06 | 17,68 | 5 894 406 | 9 831 637 431 | |
| 2025-06-02 |
|
4 | SMMT |
Summit Therapeutics Inc.
Common Stock |
M - Exercise | 74 545 | 555 754 696 | 0,01 | 2,64 | 196 799 | 1 467 192 397 | |
| 2025-04-09 |
|
4 | SMMT |
Summit Therapeutics Inc.
Common Stock |
X - Other | 3 985 055 | 555 680 151 | 0,72 | 1,58 | 6 296 387 | 877 974 639 | |
| 2024-12-18 |
|
4 | PLSE |
PULSE BIOSCIENCES, INC.
Common Stock |
X - Other | 49 312 | 450 189 | 12,30 | 11,00 | 542 432 | 4 952 079 | |
| 2024-12-18 |
|
4 | PLSE |
PULSE BIOSCIENCES, INC.
Common Stock |
X - Other | 69 020 | 630 109 | 12,30 | 11,00 | 759 220 | 6 931 199 | |
| 2024-12-18 |
|
4 | PLSE |
PULSE BIOSCIENCES, INC.
Common Stock |
X - Other | 5 187 824 | 47 516 541 | 12,26 | 11,00 | 57 066 064 | 522 681 951 | |
| 2024-12-17 |
|
4 | PLES |
PULSE BIOSCIENCES, INC.
Common Stock |
P - Purchase | 45 404 | 42 273 461 | 0,11 | 17,13 | 777 771 | 724 144 387 | |
| 2024-12-17 |
|
4 | PLSE |
PULSE BIOSCIENCES, INC.
Common Stock |
P - Purchase | 55 256 | 42 328 717 | 0,13 | 17,18 | 949 298 | 727 207 358 | |
| 2024-12-13 |
|
4 | PLSE |
PULSE BIOSCIENCES, INC.
Common Stock |
P - Purchase | 50 000 | 42 228 057 | 0,12 | 17,42 | 871 000 | 735 612 753 | |
| 2024-12-13 |
|
4 | PLSE |
PULSE BIOSCIENCES, INC.
Common Stock |
P - Purchase | 6 054 | 42 178 057 | 0,01 | 16,74 | 101 344 | 706 060 674 | |
| 2024-09-13 |
|
4 | SMMT |
Summit Therapeutics Inc.
Common Stock |
A - Award | 3 325 991 | 551 695 096 | 0,61 | 22,70 | 75 499 996 | 12 523 478 679 | |
| 2024-07-09 |
|
4 | PLSE |
PULSE BIOSCIENCES, INC.
Common Stock |
X - Other | 49 312 | 400 877 | 14,03 | ||||
| 2024-07-09 |
|
4 | PLSE |
PULSE BIOSCIENCES, INC.
Common Stock |
X - Other | 69 020 | 561 089 | 14,03 | ||||
| 2024-07-09 |
|
4 | PLSE |
PULSE BIOSCIENCES, INC.
Common Stock |
X - Other | 5 187 824 | 42 172 003 | 14,03 | ||||
| 2023-12-14 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 17 999 | 36 984 179 | 0,05 | 9,15 | 164 691 | 338 405 238 | |
| 2023-12-13 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 90 118 | 36 966 180 | 0,24 | 9,36 | 843 504 | 346 003 445 | |
| 2023-12-12 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 116 656 | 36 876 062 | 0,32 | 9,54 | 1 112 898 | 351 797 631 | |
| 2023-12-11 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 74 852 | 36 759 406 | 0,20 | 9,19 | 687 890 | 337 818 941 | |
| 2023-12-08 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 82 813 | 36 684 554 | 0,23 | 9,06 | 750 286 | 332 362 059 | |
| 2023-12-08 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
M - Exercise | 9 933 | 36 601 741 | 0,03 | 5,95 | 59 101 | 217 780 359 | |
| 2023-12-07 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 66 021 | 351 565 | 23,12 | 9,34 | 616 636 | 3 283 617 | |
| 2023-12-06 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 27 000 | 285 544 | 10,44 | 10,38 | 280 260 | 2 963 947 | |
| 2023-12-06 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
M - Exercise | 20 347 | 36 591 808 | 0,06 | 10,66 | 216 899 | 390 068 673 | |
| 2023-12-06 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
M - Exercise | 20 000 | 36 571 461 | 0,05 | 10,66 | 213 200 | 389 851 774 | |
| 2023-12-05 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 45 600 | 258 544 | 21,41 | 9,07 | 413 592 | 2 344 994 | |
| 2023-12-04 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 152 944 | 212 944 | 254,91 | 9,06 | 1 385 673 | 1 929 273 | |
| 2023-12-01 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 60 000 | 60 000 | 9,21 | 552 600 | 552 600 | ||
| 2023-12-01 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 158 600 | 36 551 461 | 0,44 | 9,44 | 1 497 184 | 345 045 792 | |
| 2023-12-01 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
M - Exercise | 1 667 | 36 392 861 | 0,00 | 5,95 | 9 919 | 216 537 523 | |
| 2023-11-30 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 124 397 | 36 391 194 | 0,34 | 8,98 | 1 117 085 | 326 792 922 | |
| 2023-11-20 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 10 000 | 36 266 797 | 0,03 | 6,11 | 61 100 | 221 590 130 | |
| 2023-11-20 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 10 000 | 36 256 797 | 0,03 | 6,09 | 60 900 | 220 803 894 | |
| 2023-11-20 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 241 | 36 246 797 | 0,00 | 6,10 | 1 470 | 221 105 462 | |
| 2023-11-09 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
M - Exercise | 9 932 | 36 246 556 | 0,03 | 5,95 | 59 095 | 215 667 008 | |
| 2023-11-09 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
M - Exercise | 3 333 | 36 236 624 | 0,01 | 5,95 | 19 831 | 215 607 913 | |
| 2023-08-28 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
M - Exercise | 1 667 | 36 233 291 | 0,00 | 5,95 | 9 919 | 215 588 081 | |
| 2023-07-27 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
M - Exercise | 1 667 | 36 231 624 | 0,00 | 5,95 | 9 919 | 215 578 163 | |
| 2023-07-07 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
M - Exercise | 1 666 | 36 229 957 | 0,00 | 5,95 | 9 913 | 215 568 244 | |
| 2023-07-07 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
M - Exercise | 65 467 | 36 228 291 | 0,18 | 2,14 | 140 099 | 77 528 543 | |
| 2023-07-07 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
M - Exercise | 65 000 | 36 162 824 | 0,18 | 2,14 | 139 100 | 77 388 443 | |
| 2023-06-16 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
X - Other | 81 025 | 492 069 | 19,71 | 2,05 | 166 101 | 1 008 741 | |
| 2023-06-16 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
X - Other | 5 683 163 | 36 097 824 | 18,69 | 2,05 | 11 650 484 | 74 000 539 | |
| 2023-05-10 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 10 022 937 | 30 414 661 | 49,15 | 6,51 | 65 249 320 | 197 999 443 | |
| 2023-03-08 |
|
4 | SMMT |
Summit Therapeutics Inc.
Common Stock |
P - Purchase | 376 489 880 | 552 354 161 | 214,08 | 1,05 | 395 314 374 | 579 971 869 | |
| 2022-12-08 |
|
4 | SMMT |
Summit Therapeutics Inc.
Common Stock |
J - Other | 9 346 434 | 171 879 226 | 5,75 | ||||
| 2022-08-18 |
|
4 | SMMT |
Summit Therapeutics Inc.
Common Stock |
P - Purchase | 94 849 203 | 162 532 792 | 140,14 | 0,97 | 92 003 727 | 157 656 808 | |
| 2022-06-10 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
X - Other | 81 025 | 411 044 | 24,55 | ||||
| 2022-06-10 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
X - Other | 5 683 163 | 20 391 724 | 38,64 | ||||
| 2022-05-25 |
|
4 | SMMT |
Summit Therapeutics Inc.
Common Stock |
J - Other | 21 135 | 67 683 589 | 0,03 | ||||
| 2022-05-23 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 110 467 | 110 467 | |||||
| 2022-05-23 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 20 000 | 20 000 | |||||
| 2021-07-02 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 3 048 780 | 14 708 561 | 26,15 | 16,40 | 49 999 992 | 241 220 400 | |
| 2021-05-21 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 11 605 | 11 605 | |||||
| 2021-05-21 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 20 000 | 20 000 | |||||
| 2021-05-14 |
|
4 | SMMT |
Summit Therapeutics Inc.
Common Stock |
P - Purchase | 11 365 921 | 67 662 454 | 20,19 | 5,24 | 59 557 426 | 354 551 259 | |
| 2020-12-30 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Warrant (right to buy) |
X - Other | −8 214 | 0 | −100,00 | ||||
| 2020-12-30 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Warrant (right to buy) |
X - Other | −376 065 | 0 | −100,00 | ||||
| 2020-12-30 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
X - Other | 8 214 | 330 019 | 2,55 | 7,01 | 57 580 | 2 313 433 | |
| 2020-12-30 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
X - Other | 376 065 | 11 659 781 | 3,33 | 7,01 | 2 636 216 | 81 735 065 | |
| 2020-11-10 |
|
4 | SMMT |
Summit Therapeutics Inc.
Common Stock |
P - Purchase | 14 071 856 | 56 296 533 | 33,33 | 3,34 | 46 999 999 | 188 030 420 | |
| 2020-10-06 |
|
4 | SMMT |
Summit Therapeutics Inc.
Common Stock |
A - Award | 9 730 539 | 9 730 539 | |||||
| 2020-09-18 | 3 | SMMT |
Summit Therapeutics Inc.
Common Stock |
42 224 677 | ||||||||
| 2020-06-17 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Warrant (right to buy) |
P - Purchase | 8 214 | 8 214 | |||||
| 2020-06-17 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Warrant (right to buy) |
P - Purchase | 376 065 | 376 065 | |||||
| 2020-06-17 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
X - Other | 54 761 | 321 805 | 20,51 | 7,01 | 383 875 | 2 255 853 | |
| 2020-06-17 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
X - Other | 2 507 112 | 11 283 716 | 28,57 | 7,01 | 17 574 855 | 79 098 849 | |
| 2020-05-19 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 20 347 | 20 347 | |||||
| 2020-05-19 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 20 000 | 20 000 | |||||
| 2019-05-17 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 13 124 | 13 124 | |||||
| 2019-05-17 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
| 2019-03-20 |
|
4 | AKAO |
Achaogen, Inc.
Common Stock, par value $0.001 per share |
S - Sale | −50 000 | 5 555 414 | −0,89 | 0,53 | −26 500 | 2 944 369 | |
| 2019-03-20 |
|
4 | AKAO |
Achaogen, Inc.
Common Stock, par value $0.001 per share |
S - Sale | −956 009 | 5 605 414 | −14,57 | 0,53 | −506 685 | 2 970 869 | |
| 2019-03-20 |
|
4 | AKAO |
Achaogen, Inc.
Common Stock, par value $0.001 per share |
S - Sale | −271 879 | 6 561 423 | −3,98 | 0,56 | −152 252 | 3 674 397 | |
| 2019-03-13 |
|
4 | AKAO |
Achaogen, Inc.
Common Stock, par value $0.001 per share |
S - Sale | −1 199 930 | 6 833 302 | −14,94 | 0,59 | −707 959 | 4 031 648 | |
| 2019-03-13 |
|
4 | AKAO |
Achaogen, Inc.
Common Stock, par value $0.001 per share |
S - Sale | −633 975 | 8 033 232 | −7,31 | 0,61 | −386 725 | 4 900 272 | |
| 2019-03-13 |
|
4 | AKAO |
Achaogen, Inc.
Common Stock, par value $0.001 per share |
S - Sale | −520 102 | 8 667 207 | −5,66 | 0,63 | −327 664 | 5 460 340 | |
| 2019-01-09 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 4 444 | 4 444 | |||||
| 2018-12-17 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
X - Other | 232 044 | 267 044 | 662,98 | 12,57 | 2 915 818 | 3 355 621 | |
| 2018-12-17 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
X - Other | 2 914 182 | 8 776 604 | 49,71 | 12,57 | 36 619 028 | 110 285 051 | |
| 2018-12-12 |
|
4 | AKAO |
Achaogen, Inc.
Common Stock, par value $0.001 per share |
P - Purchase | 306 848 | 9 187 309 | 3,46 | 1,65 | 505 010 | 15 120 473 | |
| 2018-12-12 |
|
4 | AKAO |
Achaogen, Inc.
Common Stock, par value $0.001 per share |
P - Purchase | 436 500 | 8 880 461 | 5,17 | 1,60 | 697 789 | 14 196 305 | |
| 2018-12-11 |
|
4 | AKAO |
Achaogen, Inc.
Common Stock, par value $0.001 per share |
P - Purchase | 22 431 | 8 443 961 | 0,27 | 1,40 | 31 394 | 11 818 168 | |
| 2018-11-27 |
|
4 | AKAO |
Achaogen, Inc.
Common Stock, par value $0.001 per share |
P - Purchase | 77 585 | 8 421 530 | 0,93 | 1,68 | 129 963 | 14 106 905 | |
| 2018-11-27 |
|
4 | AKAO |
Achaogen, Inc.
Common Stock, par value $0.001 per share |
P - Purchase | 80 175 | 8 343 945 | 0,97 | 1,89 | 151 643 | 15 781 738 | |
| 2018-11-23 |
|
4 | AKAO |
Achaogen, Inc.
Common Stock, par value $0.001 per share |
P - Purchase | 231 495 | 8 263 770 | 2,88 | 1,93 | 446 947 | 15 954 861 | |
| 2018-11-20 |
|
4 | AKAO |
Achaogen, Inc.
Common Stock, par value $0.001 per share |
P - Purchase | 4 648 | 8 032 275 | 0,06 | 1,62 | 7 525 | 13 003 450 | |
| 2018-05-24 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
| 2018-05-15 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 21 353 | 5 862 422 | 0,37 | 23,16 | 494 535 | 135 773 694 | |
| 2018-05-07 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 100 255 | 100 255 | 11,43 | 1 146 316 | 1 146 316 | ||
| 2018-05-07 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 30 000 | 30 000 | 11,54 | 346 338 | 346 338 | ||
| 2018-05-07 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 846 625 | 8 027 627 | 11,79 | 11,31 | 9 579 477 | 90 831 797 | |
| 2018-04-27 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 102 849 | 7 181 002 | 1,45 | 12,96 | 1 333 160 | 93 082 302 | |
| 2018-04-27 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 50 000 | 7 078 153 | 0,71 | 12,96 | 647 755 | 91 698 180 | |
| 2018-04-27 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 77 247 | 7 028 153 | 1,11 | 13,02 | 1 005 949 | 91 524 122 | |
| 2018-04-23 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 132 487 | 6 950 906 | 1,94 | 13,07 | 1 730 969 | 90 814 977 | |
| 2018-04-23 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 216 150 | 6 818 419 | 3,27 | 13,23 | 2 860 421 | 90 231 548 | |
| 2018-04-23 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 119 700 | 6 602 269 | 1,85 | 12,76 | 1 527 264 | 84 239 010 | |
| 2018-04-04 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 47 361 | 6 482 569 | 0,74 | 12,44 | 588 977 | 80 616 580 | |
| 2018-04-04 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 24 100 | 6 435 208 | 0,38 | 12,46 | 300 240 | 80 170 465 | |
| 2018-04-04 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 20 000 | 6 411 108 | 0,31 | 12,51 | 250 202 | 80 203 602 | |
| 2018-03-30 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 30 000 | 6 391 108 | 0,47 | 12,44 | 373 095 | 79 483 015 | |
| 2018-03-21 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 25 000 | 6 361 108 | 0,39 | 11,09 | 277 155 | 70 520 516 | |
| 2018-03-21 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 11 300 | 6 336 108 | 0,18 | 11,20 | 126 557 | 70 962 509 | |
| 2018-03-16 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 30 000 | 6 324 808 | 0,48 | 11,23 | 336 756 | 70 997 235 | |
| 2018-03-16 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 19 660 | 6 294 808 | 0,31 | 11,57 | 227 488 | 72 837 853 | |
| 2018-03-13 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 20 000 | 6 275 148 | 0,32 | 11,39 | 227 802 | 71 474 563 | |
| 2018-03-13 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 50 000 | 6 255 148 | 0,81 | 11,41 | 570 520 | 71 373 741 | |
| 2018-03-02 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 96 790 | 6 205 148 | 1,58 | 10,14 | 981 683 | 62 935 093 | |
| 2018-03-02 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 410 606 | 6 108 358 | 7,21 | 10,33 | 4 243 285 | 63 124 993 | |
| 2018-03-02 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 20 000 | 5 697 752 | 0,35 | 10,70 | 213 928 | 60 945 434 | |
| 2018-02-15 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 9 442 | 5 677 752 | 0,17 | 10,96 | 103 487 | 62 229 865 | |
| 2018-02-15 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 558 | 5 668 310 | 0,01 | 10,97 | 6 119 | 62 155 286 | |
| 2018-01-05 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 50 000 | 5 667 752 | 0,89 | 11,51 | 575 500 | 65 235 826 | |
| 2018-01-05 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 15 000 | 5 617 752 | 0,27 | 10,89 | 163 353 | 61 178 443 | |
| 2017-12-20 |
|
4 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
P - Purchase | 95 012 | 5 602 752 | 1,73 | 11,13 | 1 057 493 | 62 359 190 | |
| 2017-12-13 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 20 556 | 5 841 069 | 0,35 | 22,44 | 461 277 | 131 073 588 | |
| 2017-12-11 | 3 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
11 087 650 | ||||||||
| 2017-12-11 | 3 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
5 652 080 | ||||||||
| 2017-12-11 | 3 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
11 087 650 | ||||||||
| 2017-12-11 | 3 | AKAO |
Achaogen Inc
Common Stock, par value $0.001 per share |
5 652 080 | ||||||||
| 2017-11-06 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 65 000 | 65 000 | |||||
| 2017-10-23 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 22 901 | 5 820 513 | 0,40 | 22,79 | 521 868 | 132 637 850 | |
| 2017-09-26 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 2 000 000 | 5 797 612 | 52,66 | 15,02 | 30 040 000 | 87 080 132 | |
| 2017-09-18 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 7 497 | 3 797 612 | 0,20 | 15,50 | 116 175 | 58 848 555 | |
| 2017-09-18 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 23 703 | 3 790 115 | 0,63 | 15,12 | 358 283 | 57 289 483 | |
| 2017-09-18 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 500 | 3 766 412 | 0,01 | 16,22 | 8 108 | 61 072 371 | |
| 2017-09-18 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 125 000 | 3 765 912 | 3,43 | 15,70 | 1 963 088 | 59 142 518 | |
| 2017-09-18 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 71 598 | 3 640 912 | 2,01 | 14,38 | 1 029 515 | 52 353 038 | |
| 2017-09-18 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 47 450 | 3 569 314 | 1,35 | 14,57 | 691 332 | 52 003 834 | |
| 2017-09-18 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 53 820 | 3 521 864 | 1,55 | 13,90 | 748 136 | 48 956 375 | |
| 2017-09-18 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 30 050 | 3 468 044 | 0,87 | 12,77 | 383 859 | 44 300 794 | |
| 2017-09-18 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 50 300 | 3 437 994 | 1,48 | 11,66 | 586 609 | 40 094 574 | |
| 2017-08-03 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 68 964 | 3 387 694 | 2,08 | 23,70 | 1 634 723 | 80 301 899 | |
| 2017-08-03 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 38 290 | 3 318 730 | 1,17 | 25,12 | 961 883 | 83 369 816 | |
| 2017-08-03 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 14 710 | 3 280 440 | 0,45 | 24,37 | 358 512 | 79 950 884 | |
| 2017-08-03 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 6 868 | 3 265 730 | 0,21 | 24,02 | 164 956 | 78 436 303 | |
| 2017-08-03 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 80 618 | 3 258 862 | 2,54 | 23,48 | 1 892 588 | 76 505 044 | |
| 2017-08-03 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 8 000 | 3 178 244 | 0,25 | 22,75 | 181 984 | 72 298 695 | |
| 2017-08-03 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 17 010 | 3 170 244 | 0,54 | 20,94 | 356 274 | 66 400 761 | |
| 2017-08-03 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 42 990 | 3 153 234 | 1,38 | 20,20 | 868 398 | 63 695 327 | |
| 2017-05-24 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 2 000 | 3 110 244 | 0,06 | 28,07 | 56 148 | 87 316 990 | |
| 2017-05-24 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 28 600 | 3 108 244 | 0,93 | 27,63 | 790 161 | 85 874 565 | |
| 2017-05-24 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 18 600 | 3 079 644 | 0,61 | 26,69 | 496 397 | 82 189 539 | |
| 2017-05-24 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 6 800 | 3 061 044 | 0,22 | 26,67 | 181 336 | 81 628 860 | |
| 2017-05-24 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 27 928 | 3 054 244 | 0,92 | 26,15 | 730 289 | 79 865 426 | |
| 2017-05-11 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 7 500 | 3 026 316 | 0,25 | 21,52 | 161 378 | 65 117 241 | |
| 2017-05-11 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 10 100 | 3 018 816 | 0,34 | 20,55 | 207 545 | 62 033 650 | |
| 2017-05-11 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 19 489 | 3 008 716 | 0,65 | 21,47 | 418 351 | 64 585 098 | |
| 2017-05-11 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 5 000 | 2 989 227 | 0,17 | 20,07 | 100 360 | 59 999 764 | |
| 2017-05-11 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 1 300 | 2 984 227 | 0,04 | 19,43 | 25 256 | 57 977 562 | |
| 2017-05-02 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 5 000 | 2 982 927 | 0,17 | 23,40 | 117 000 | 69 800 492 | |
| 2017-05-02 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 19 348 | 2 977 927 | 0,65 | 23,81 | 460 715 | 70 910 398 | |
| 2017-05-02 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 35 000 | 35 000 | 24,00 | 840 000 | 840 000 | ||
| 2017-05-02 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 25 000 | 2 958 579 | 0,85 | 23,85 | 596 250 | 70 562 109 | |
| 2017-04-27 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 200 | 2 933 579 | 0,01 | 22,95 | 4 590 | 67 325 638 | |
| 2017-04-27 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 10 000 | 2 933 379 | 0,34 | 24,47 | 244 690 | 71 776 851 | |
| 2017-04-27 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 25 187 | 2 923 379 | 0,87 | 24,94 | 628 113 | 72 903 226 | |
| 2017-04-19 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 37 905 | 2 898 192 | 1,33 | 25,37 | 961 801 | 73 538 724 | |
| 2017-04-19 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 26 000 | 2 860 287 | 0,92 | 24,35 | 633 048 | 69 642 268 | |
| 2017-04-19 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 53 228 | 2 834 287 | 1,91 | 23,28 | 1 239 361 | 65 993 539 | |
| 2017-04-19 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 32 990 | 2 781 059 | 1,20 | 22,24 | 733 533 | 61 836 847 | |
| 2017-04-19 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 28 000 | 2 748 069 | 1,03 | 26,02 | 728 588 | 71 507 503 | |
| 2017-04-19 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 33 819 | 2 720 069 | 1,26 | 25,06 | 847 437 | 68 159 489 | |
| 2017-04-19 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 73 900 | 2 686 250 | 2,83 | 25,39 | 1 876 173 | 68 198 515 | |
| 2017-04-19 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 10 500 | 2 612 350 | 0,40 | 24,34 | 255 591 | 63 589 824 | |
| 2017-04-19 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 22 900 | 2 601 850 | 0,89 | 23,15 | 530 181 | 60 238 031 | |
| 2017-04-10 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 22 764 | 2 578 950 | 0,89 | 21,40 | 487 081 | 55 181 793 | |
| 2017-04-10 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 9 200 | 2 556 186 | 0,36 | 20,38 | 187 450 | 52 082 290 | |
| 2017-04-10 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 94 100 | 2 546 986 | 3,84 | 19,59 | 1 843 795 | 49 905 644 | |
| 2017-04-10 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 44 200 | 2 452 886 | 1,84 | 19,70 | 870 873 | 48 329 213 | |
| 2017-04-10 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 21 200 | 2 408 686 | 0,89 | 18,54 | 393 048 | 44 657 038 | |
| 2017-03-20 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 105 486 | 2 378 486 | 4,64 | 23,01 | 2 427 127 | 54 726 584 | |
| 2017-03-20 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 25 859 | 2 273 000 | 1,15 | 24,07 | 622 452 | 54 713 383 | |
| 2017-03-20 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 3 500 | 2 247 141 | 0,16 | 24,93 | 87 266 | 56 027 967 | |
| 2017-03-20 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 69 162 | 2 243 641 | 3,18 | 24,14 | 1 669 847 | 54 170 468 | |
| 2017-03-20 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 1 120 | 2 174 479 | 0,05 | 22,54 | 25 239 | 49 001 884 | |
| 2017-02-22 |
|
4 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
P - Purchase | 41 624 | 2 173 359 | 1,95 | 11,64 | 484 503 | 25 297 899 | |
| 2017-02-16 | 3 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
4 263 470 | ||||||||
| 2017-02-16 | 3 | PLSE |
Pulse Biosciences, Inc.
Common Stock |
4 263 470 | ||||||||
| 2015-05-28 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
U - Other | −170 379 | 0 | −100,00 | 261,25 | −44 511 514 | ||
| 2015-05-28 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
U - Other | −8 404 | 0 | −100,00 | 261,25 | −2 195 545 | ||
| 2015-05-28 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
U - Other | −8 404 | 0 | −100,00 | 261,25 | −2 195 545 | ||
| 2015-05-28 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
U - Other | −8 404 | 0 | −100,00 | 261,25 | −2 195 545 | ||
| 2015-05-28 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
U - Other | −8 404 | 0 | −100,00 | 261,25 | −2 195 545 | ||
| 2015-05-28 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
U - Other | −8 404 | 0 | −100,00 | 261,25 | −2 195 545 | ||
| 2015-05-28 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
U - Other | −21 908 | 0 | −100,00 | 261,25 | −5 723 465 | ||
| 2015-05-28 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
U - Other | −21 908 | 0 | −100,00 | 261,25 | −5 723 465 | ||
| 2015-05-28 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
U - Other | −21 908 | 0 | −100,00 | 261,25 | −5 723 465 | ||
| 2015-05-28 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
U - Other | −21 908 | 0 | −100,00 | 261,25 | −5 723 465 | ||
| 2015-05-28 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
U - Other | −21 908 | 0 | −100,00 | 261,25 | −5 723 465 | ||
| 2015-05-28 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
U - Other | −21 908 | 0 | −100,00 | 261,25 | −5 723 465 | ||
| 2015-05-28 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
U - Other | −21 908 | 0 | −100,00 | 261,25 | −5 723 465 | ||
| 2015-05-28 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
U - Other | −13 225 531 | 0 | −100,00 | 261,25 | −3 455 169 974 | ||
| 2015-05-28 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | −4 785 | 13 225 531 | −0,04 | ||||
| 2015-05-28 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | −152 635 | 13 230 316 | −1,14 | ||||
| 2015-02-13 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
J - Other | −200 740 | 170 379 | −54,09 | ||||
| 2015-02-13 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | −617 | 13 382 951 | 0,00 | ||||
| 2015-02-13 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | −2 000 | 13 383 568 | −0,01 | ||||
| 2015-02-13 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | −35 517 | 13 385 568 | −0,26 | ||||
| 2015-02-13 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | −2 000 | 13 421 085 | −0,01 | ||||
| 2015-02-13 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | −1 504 | 13 423 085 | −0,01 | ||||
| 2015-02-13 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | −7 000 | 13 424 589 | −0,05 | ||||
| 2015-02-13 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | −10 000 | 13 431 589 | −0,07 | ||||
| 2015-02-13 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | −1 000 | 13 441 589 | −0,01 | ||||
| 2015-02-13 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | −5 450 | 13 442 589 | −0,04 | ||||
| 2015-02-13 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | −5 413 | 13 448 039 | −0,04 | ||||
| 2015-02-13 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | −37 926 | 13 453 452 | −0,28 | ||||
| 2014-02-12 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | 470 | 30 312 | 1,57 | ||||
| 2014-02-12 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | 470 | 21 908 | 2,19 | ||||
| 2014-02-12 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | 470 | 21 908 | 2,19 | ||||
| 2014-02-12 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | 470 | 21 908 | 2,19 | ||||
| 2014-02-12 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | 470 | 21 908 | 2,19 | ||||
| 2014-02-12 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | 470 | 21 908 | 2,19 | ||||
| 2014-02-12 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | 470 | 21 908 | 2,19 | ||||
| 2014-02-12 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | −3 290 | 13 492 378 | −0,02 | ||||
| 2013-12-19 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
J - Other | −5 000 | 371 119 | −1,33 | ||||
| 2013-02-25 |
|
5/A | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | 21 438 | 21 438 | |||||
| 2013-02-25 |
|
5/A | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | 8 404 | 29 842 | 39,20 | ||||
| 2013-02-25 |
|
5/A | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | −8 404 | 13 291 888 | −0,06 | ||||
| 2013-02-25 |
|
5/A | PCYC |
PHARMACYCLICS INC
Common Stock |
J - Other | −125 000 | 376 119 | −24,94 | ||||
| 2013-02-25 |
|
5/A | PCYC |
PHARMACYCLICS INC
Common Stock |
J - Other | −995 | 501 119 | −0,20 | ||||
| 2013-02-25 |
|
5/A | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | 21 438 | 21 438 | |||||
| 2013-02-25 |
|
5/A | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | 21 438 | 21 438 | |||||
| 2013-02-25 |
|
5/A | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | 21 438 | 21 438 | |||||
| 2013-02-25 |
|
5/A | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | 21 438 | 21 438 | |||||
| 2013-02-25 |
|
5/A | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | 21 438 | 21 438 | |||||
| 2013-02-25 |
|
5/A | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | 21 438 | 21 438 | |||||
| 2013-02-25 |
|
5/A | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | −150 066 | 13 300 292 | −1,12 | ||||
| 2013-02-13 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | 21 438 | 21 438 | |||||
| 2013-02-13 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | 8 404 | 29 842 | 39,20 | ||||
| 2013-02-13 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | −8 404 | 11 922 774 | −0,07 | ||||
| 2013-02-13 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
J - Other | −125 000 | 376 119 | −24,94 | ||||
| 2013-02-13 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
J - Other | −995 | 501 119 | −0,20 | ||||
| 2013-02-13 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | 21 438 | 21 438 | |||||
| 2013-02-13 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | 21 438 | 21 438 | |||||
| 2013-02-13 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | 21 438 | 21 438 | |||||
| 2013-02-13 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | 21 438 | 21 438 | |||||
| 2013-02-13 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | 21 438 | 21 438 | |||||
| 2013-02-13 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | 21 438 | 21 438 | |||||
| 2013-02-13 |
|
5 | PCYC |
PHARMACYCLICS INC
Common Stock |
G - Gift | −150 066 | 13 300 292 | −1,12 | ||||
| 2012-09-25 |
|
4/A | PCYC |
PHARMACYCLICS INC
Common Stock |
J - Other | −22 000 | 502 114 | −4,20 | ||||
| 2012-04-04 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
J - Other | −22 000 | 502 114 | −4,20 | ||||
| 2009-08-04 |
|
4 | PCYC |
PHARMACYCLICS INC
Subscription Rights (right to buy) |
X - Other | −133 352 | 0 | −100,00 | ||||
| 2009-08-04 |
|
4 | PCYC |
PHARMACYCLICS INC
Subscription Rights (right to buy) |
X - Other | −4 754 870 | 0 | −100,00 | ||||
| 2009-08-04 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 133 352 | 649 112 | 25,86 | 1,28 | 170 691 | 830 863 | |
| 2009-08-04 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 4 754 870 | 9 829 434 | 93,70 | 1,28 | 6 086 234 | 12 581 676 | |
| 2007-09-19 | 3 | PCYC |
PHARMACYCLICS INC
Common Stock |
536 760 | ||||||||
| 2007-09-19 | 3 | PCYC |
PHARMACYCLICS INC
Common Stock |
3 928 389 |
